Low impact
CNBC's Jim Cramer states that biotech has become the market's hottest group, highlighting a strong move in the sector partly due to the change in FDA leadership.
Finnhub07/09, 10:35 PM
Related assets
Coming up for XBI
Explore next
Latest XBI news
Jin1008/19, 08:12 PM
iShares Biotechnology ETF rose 3.2% and State Street SPDR S&P Biotech ETF rose 2.9%.
ZeroHedge07/29, 11:05 PM
FirstSquawk07/17, 01:16 AM